NIH-funded research NIH-funded research

Automatic treatment planning for cervical cancer brachytherapy in low-resource areas

Official title: SBIR PHASE II, TOPIC 431: AUTOMATIC TREATMENT PLANNING OF CERVICAL CANCER HIGH-DOSE RATE BRACHYTHERPAY FOR LOW-RESOURCE SETTINGS.

Funded at Veloxai LLC · NIH-11182172 · Data updated 2026-11-12

This study is testing a new software called AutoBrachy that helps doctors plan treatments for cervical cancer more easily and effectively, especially in places that may not have a lot of resources, so that patients can get better care.

More Cervical Cancer research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeloxai LLC
NIH-funded
Lab location1 site (Austin, United States)
Project startSeptember 4, 2024
Project endSeptember 3, 2026
Funding year2024
Award (this year)$2,000,000
NIH project number75N91024C00073-0-9999-1
Project IDNIH-11182172 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with cervical cancer who are receiving treatment in low-resource environments.

Less likely to help

Patients with cervical cancer in high-resource settings may not benefit from this research as they typically have access to existing treatment planning expertise and resources.

What this research studies

This research focuses on developing a software system called AutoBrachy that automates the treatment planning process for high-dose rate brachytherapy (HDRBT) in cervical cancer patients, particularly in low-resource settings. The project aims to enhance the usability and effectiveness of HDRBT by improving algorithms and ensuring the software can be used across various institutions and equipment. By conducting clinical validation studies, the research seeks to demonstrate the software's reliability and applicability, ultimately improving treatment outcomes for patients in underserved regions.

Why it matters

Potential benefit: If successful, this research could significantly improve survival rates and reduce recurrence of cervical cancer in patients from low-resource settings.

How similar studies have gone: Other research has shown promise in utilizing automated systems for treatment planning in various medical fields, indicating potential success for this novel approach in brachytherapy.

Where this research is happening

  • Veloxai LLC
    Austin, United States
    Active

Researchers

  • Principal investigator: Ghimire, Kanchan — Veloxai LLC
  • Study coordinator: Ghimire, Kanchan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.